General
The Powerful Potential of Open Collaboration
Explore key takeaways from the Consortium’s first in-person meeting at the Onsemble Conference and welcome new members.
Let’s Get Ethical
Advarra's IRB Chairs Luke Gelinas and Amanda Higley discuss hot topics in clinical research, including cannabis studies and data ownership.
A Journey in Support of Diversity
Advarra's Sergio Armani introduces ACRP's Ride for Diversity program and why it's important to him personally and to the research community.
Clinical Trial Superheroes 2022
This April, be sure to stay tuned as we unveil and celebrate the unsung clinical trial superheroes across our industry.
The Impact of Digital Transformation in Clinical Trials
Explore what digital acceleration means for clinical research and how Advarra views digital transformation in the industry.
Improving Regulatory Workflows in Study Startup
This newsletter outlines the Consortium's efforts to improve regulatory workflows in study startups.
The Rise of the Clinical Research Network: Using Technology to Connect Sites and Sponsors
An integrated approach to the clinical research industry’s technology landscape can improve access and diversity, save time, and better serve patients
Clinical Conductor Study Build
Learn how Advarra’s Clinical Conductor Study Build services expedites study activation, saves time, and increases protocol compliance.
Advarra’s Support for Institutions
Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.
What Level of Review Does Your Study Need?
In this infographic, we share useful information for investigators to know which level of IRB review likely applies to their study.
Beginner’s Guide to Clinical Trial Management Systems
A clinical trial management system (CTMS) can bring powerful efficiencies, insights, and compliance to sites' day-to-day operations.
Advarra Trend Report: The Future of Clinical Staff Development Planning
This report is based on surveys and interviews with organizational leaders from top U.S. biotech and pharmaceutical companies.